<DOC>
	<DOCNO>NCT02104284</DOCNO>
	<brief_summary>Asthmatic patient non-asthmatic control recruit prospectively four referral hospital Korea . Participants challenge methacholine mannitol inhalation different day . Their diagnostic utility evaluate calculate sensitivity specificity asthma diagnosis . Response-dose-ratio also compare .</brief_summary>
	<brief_title>A Comparative Bronchial Provocation Study With Mannitol Methacolinie Korean Population</brief_title>
	<detailed_description>This study prospective , multicenter study perform four referral hospital Korea : Seoul National University Hospital , Samsung Medical Center , Ajou University Hospital , Hanyang University Medical Center . Hospital-based recruitment perform asthmatic patient non-asthmatic control . Asthmatic patient define diagnosed asthma specialist physician ; recurrent symptom asthma ( wheeze dyspnea ) use anti-asthmatic medication 6 month enrollment . Non-asthmatic control voluntarily recruit hospital visitor ; include never wheeze physician diagnose asthma . Common inclusion criterion Korean adult age 18 70 year could understand perform lung function test bronchial challenge . Exclusion criterion one following : history recent respiratory infection ( within last 4 week ) , history recent surgery , history heart disease could impose risk bronchial challenge , history uncontrolled hypertension , current smoker ex-smokers 10 pack-years , history know pulmonary disease exception asthma , pregnancy lactation , severe obesity ( body mass index [ BMI ] &gt; 35 kg/m2 ) , history health condition consider inappropriate participation study , pre-bronchodilator predictive value force expiratory volume 1 second ( FEV1 ) &lt; 70 % . All participant underwent methacholine bronchial challenge test mannitol challenge test different day , separate least 24 h , previous reports.7 , 10 All asthmatic patient stop anti-asthma medication test accord predetermined protocol . The protocol approve Institutional Review Board Seoul National University Hospital . All subject give write informed consent . Methacholine challenge test &gt; The methacholine challenge test perform previously described.11 , 12 Pulmonary function test carry use spirometry system ( SensorMedics 2130 ; SensorMedics , CA , USA ) . The methacholine challenge test perform use Chai method13 minor modification . Briefly , methacholine prepare following concentration , dilute saline : 0.25 , 0.625 , 1 , 4 , 16 , 25 mg/mL . Methacholine deliver aerosol Rosenthal-French dosimeter ( Laboratory Applied Immunology , Inc. , Baltimore , MD ) nebulizer . Subjects instruct inhale five inspiratory capacity breath increase methacholine concentration 0.25 25 mg/mL . The methacholine concentration cause 20 % decrease FEV1 baseline define PC20 . AHR define positive PC20 &lt; 16 mg/mL . Mannitol challenge test &gt; A commercial mannitol ( Aridolâ„¢ ; BL &amp; H Co. , Ltd. , South Korea ) kit use , challenge test perform accord manufacturer 's protocols.14 The mannitol capsule dose start 0 mg increase total cumulative dose 635 mg. Each capsule place inhalation device , hole make press device button inhalation . After deep breath mannitol , FEV1 measure 60 second . The test consider positive FEV1 value decrease 15 % compare baseline FEV1 . The cumulative mannitol dose cause 15 % decrease FEV1 baseline define PD15 . If FEV1 decline 15 % , dose increase cumulative dose 635 mg reach . If FEV1 fall 15 % last dose , test consider negative .</detailed_description>
	<mesh_term>Mannitol</mesh_term>
	<mesh_term>Methacholine Chloride</mesh_term>
	<criteria>Common inclusion criterion Korean adult age 18 70 year could understand perform lung function test bronchial challenge . History recent respiratory infection ( within last 4 week ) History recent surgery History heart disease could impose risk bronchial challenge History uncontrolled hypertension Current smokers exsmokers 10 packyears History know pulmonary disease exception asthma Pregnancy lactation Severe obesity ( body mass index [ BMI ] &gt; 35 kg/m2 ) History health condition consider inappropriate participation study Prebronchodilator predictive value force expiratory volume 1 second ( FEV1 ) &lt; 70 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Bronchial provocation test</keyword>
	<keyword>Mannitol</keyword>
	<keyword>Methacholine</keyword>
	<keyword>Bronchial hyperreactivity</keyword>
	<keyword>Sensitivity specificity</keyword>
</DOC>